(Q77118216)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710883%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

review article

1 reference

title

Minocycline for the treatment of rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710883%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

1 reference

G S Alarcón

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710883%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710883%20AND%20SRC:MED&resulttype=core&format=json

Rheumatic Diseases Clinics of North America

3 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710883%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710883%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710883%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

489-499

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710883%20AND%20SRC:MED&resulttype=core&format=json

Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Antibiotic Treatment of Venereal Disease and Reiter's Syndrome in a Greenland Population

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

ISOLATION AND CHARACTERIZATION OF MYCOPLASMAS (PPLO) FROM PATIENTS WITH RHEUMATOID ARTHRITIS, SYSTEMIC LUPUS ERYTHEMATOSUS AND REITER'S SYNDROME.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Science, medicine, and the future. Treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Second-line drug therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Purification of rabbit bone inhibitor of collagenase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Effect of minocycline on prostaglandin formation in gingival fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

In vivo suppression of neutrophil chemotaxis by systemically and topically administered tetracycline

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Effect of tetracycline on the phagocytic function of human leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Selective endothelial growth inhibition by tetracyclines that inhibit collagenase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Minocycline-induced cell-mediated hypersensitivity pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Rheumatoid arthritis. Pathophysiology and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

The Anticollagenolytic Potential of Lymecycline in the Long‐Term Treatment of Reactive Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

The problem of therapeutic equivalence with paired qualitative data: an example from a clinical trial using haemophiliacs with an inhibitor to factor VIII.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Are antibiotics of any use in reactive arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Effects of tetracycline on leukotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Sustained-release sodium fluoride in the management of established postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Minocycline treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Anti-Inflammatory Effects Of Antimicrobial Agents: An In Vivo Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Intracranial hypertension and minocycline

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Tetracycline in the treatment of rheumatoid arthritis. A double blind controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Specificity of the anticollagenase action of tetracyclines: relevance to their anti-inflammatory potential

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Minocycline-induced Sweet's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Tetracyclines are potent scavengers of the superoxide radical

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Mitochondrial biogenesis during the activation of lymphocytes by mitogens: the immunosuppressive action of tetracyclines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Minocycline-induced acute interstitial nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Scavenging of hypochlorous acid by tetracycline, rifampicin and some other antibiotics: a possible antioxidant action of rifampicin and tetracycline?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Effect of antimicrobial agents on human polymorphonuclear leukocyte microbicidal function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Therapy for rheumatoid arthritis: combinations of disease-modifying drugs and new paradigms of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Inverting the therapeutic pyramid: observations and recommendations on new directions in rheumatoid arthritis therapy based on the author's experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Collagenase at Sites of Cartilage Erosion in the Rheumatoid Joint

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970022-3

7 January 2021

10.1016/S0889-857X(05)70022-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9710883%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference